2(nd) Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
Resuscitation. 2023 Nov;192:109935. doi: 10.1016/j.resuscitation.2023.109935. Epub 2023 Aug 11.
The severity of tissue hypoxia is routinely assessed by serum lactate. We aimed to determine whether early lactate levels predict outcomes in refractory out-of-hospital cardiac arrest (OHCA) treated by conventional and extracorporeal cardiopulmonary resuscitation (ECPR).
This study is a post-hoc analysis of a randomized Prague OHCA study (NCT01511666) assessing serum lactate levels in refractory OHCA treated by ECPR (the ECPR group) or conventional resuscitation with prehospital achieved return of spontaneous circulation (the ROSC group). Lactate concentrations measured on admission and every 4 hours (h) during the first 24 h were used to determine their relationship with the neurological outcome (the best Cerebral Performance Category score within 180 days post-cardiac arrest).
In the ECPR group (92 patients, median age 58.5 years, 83% male) 26% attained a favorable neurological outcome. In the ROSC group (82 patients, median age 55 years, 83% male) 59% achieved a favorable neurological outcome. In ECPR patients lactate concentrations could discriminate favorable outcome patients, but not consistently in the ROSC group. On admission, serum lactate >14.0 mmol/L for ECPR (specificity 87.5%, sensitivity 54.4%) and >10.8 mmol/L for the ROSC group (specificity 83%, sensitivity 41.2%) predicted an unfavorable outcome.
In refractory OHCA serum lactate concentrations measured anytime during the first 24 h after admission to the hospital were found to correlate with the outcome in patients treated by ECPR but not in patients with prehospital ROSC. A single lactate measurement is not enough for a reliable outcome prediction and cannot be used alone to guide treatment.
血清乳酸水平通常用于评估组织缺氧的严重程度。我们旨在确定在接受常规和体外心肺复苏(ECPR)治疗的难治性院外心脏骤停(OHCA)患者中,早期乳酸水平是否可以预测预后。
这是一项对布拉格 OHCA 研究(NCT01511666)进行的事后分析,该研究评估了接受 ECPR(ECPR 组)或院前自主循环恢复(ROSC 组)的难治性 OHCA 患者的血清乳酸水平。入院时和前 24 小时内每 4 小时(h)测量的乳酸浓度用于确定它们与神经功能预后(心脏骤停后 180 天内最佳脑功能分类评分)的关系。
在 ECPR 组(92 例患者,中位年龄 58.5 岁,83%为男性)中,26%的患者获得了良好的神经功能预后。在 ROSC 组(82 例患者,中位年龄 55 岁,83%为男性)中,59%的患者获得了良好的神经功能预后。在 ECPR 患者中,乳酸浓度可以区分预后良好的患者,但在 ROSC 组中并不一致。入院时,ECPR 组血清乳酸浓度>14.0mmol/L(特异性 87.5%,敏感性 54.4%)和 ROSC 组>10.8mmol/L(特异性 83%,敏感性 41.2%)预测预后不良。
在难治性 OHCA 患者中,入院后前 24 小时内任何时间测量的血清乳酸浓度与接受 ECPR 治疗的患者的预后相关,但与院前 ROSC 的患者无关。单次乳酸测量不足以进行可靠的预后预测,不能单独用于指导治疗。